Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | POLA1 | P09884 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6829456 | 1.00 | L3MBTL1 (0.53) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL26624695 | 1.00 | L3MBTL1 (0.53) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL2499676 | 1.00 | L3MBTL1 (0.53) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL16489317 | 1.00 | L3MBTL1 (0.53) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL30179450 | 1.00 | L3MBTL1 (0.53) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL12086462 | 0.98 | TSHR (0.54) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL27932299 | 0.98 | TSHR (0.54) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14956983 | 0.92 | TSHR (0.56) | L3MBTL1TSHRLMNAALDH1A1KMT2A | |
| SCHEMBL10414866 | 0.90 | EPHX2 (0.55) | L3MBTL1TSHRLMNAALDH1A1EPHX2 | |
| SCHEMBL10414867 | 0.90 | EPHX2 (0.55) | L3MBTL1TSHRLMNAALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108852954-A | Massage essential oil | 袁浩卿 | 2018-11-23 | — | — | CN | claimed |
| CN-1958011-A | Application of extractive and effective parts of datura flower in preparing medication for anti tumor | SANGDIYA MEDICINE TECH SHANGHA (CN) | 2007-05-09 | — | — | CN | claimed |
| US-20210085645-A1 | SWINE MATERNAL NEONATAL PHEROMONE | TEXAS TECH UNIVERSITY SYSTEM (US) | 2021-03-25 | — | — | US | disclosed |
| CN-108852954-A | Massage essential oil | 袁浩卿 | 2018-11-23 | — | — | CN | disclosed |
| CN-108852954-A | Massage essential oil | 袁浩卿 | 2018-11-23 | — | — | CN | disclosed |
| CN-108315140-A | A kind of preparation method for the green and healthy pure grain wine promoting physical efficiency, strengthen immunity | 广州市众颐康酒业有限公司 | 2018-07-24 | — | — | CN | disclosed |
| US-9902632-B2 | Waste treatment method | EARTH RENEWAL GROUP, LLC (US) | 2018-02-27 | — | — | US | disclosed |
| US-20170203983-A1 | WASTE TREATMENT PROCESS | EARTH RENEWAL GROUP, LLC (US) | 2017-07-20 | — | — | US | disclosed |
| US-9611158-B2 | Waste treatment process | EARTH RENEWAL GROUP, LLC (US) | 2017-04-04 | — | — | US | disclosed |
| CN-105944070-A | Medicine preparation for treating intensive care respiratory system infection and preparation method thereof | 姚鲁肃 | 2016-09-21 | — | — | CN | disclosed |
| US-20160159670-A1 | WASTE TREATMENT PROCESS | EARTH RENEWAL GROUP, LLC (US) | 2016-06-09 | — | — | US | disclosed |
| EP-2632863-B1 | WASTE TREATMENT PROCESS | EARTH RENEWAL GROUP LLC (US) | 2016-05-11 | — | — | EP | disclosed |
| US-9272936-B2 | Waste treatment process | EARTH RENEWAL GROUP, LLC (US) | 2016-03-01 | — | — | US | disclosed |
| US-20130306575-A1 | WASTE TREATMENT PROCESS | EARTH RENEWAL GROUP, LLC (US) | 2013-11-21 | — | — | US | disclosed |
| US-20120080383-A1 | WASTE TREATMENT PROCESS | EARTH RENEWAL GROUP, LLC (US) | 2012-04-05 | — | — | US | disclosed |
| CN-1958011-A | Application of extractive and effective parts of datura flower in preparing medication for anti tumor | SANGDIYA MEDICINE TECH SHANGHA (CN) | 2007-05-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210085645-A1 | SWINE MATERNAL NEONATAL PHEROMONE | PIGS, KISS1R, PGF | L3MBTL1 767/4885TSHR 3919/4885LMNA 2301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.